The JAK/STAT3 axis: A comprehensive drug target for solid malignancies.

Abstract:

:Intercellular communication between tumor cells, immune cells and the stroma characterises the tumor microenvironment, which is instrumental for establishing the ecological niche that fosters tumor growth and metastasis. While tumor cell intrinsic STAT3 signaling provides a crucial axis to support cell proliferation and survival, it also regulates many activities of the non-transformed cells that collectively make up the tumor microenvironment. Accordingly, excessive activation of STAT3 is a hallmark of many malignancies, and often occurs in response to cytokines of the IL-6 and IL-10 families. However, tumor extrinsic STAT3 signaling also regulates the effector function of tumor-associated immune and stromal cells, which support the growth of tumors by suppressing the host's anti-tumor immune response. Given that STAT3 mediates tumorigenic effects in many cell types, the molecular players of STAT3 signaling and its upstream JAK kinases provide viable therapeutic targets for the treatment of cancer. Here we provide an update on novel insights into the role of STAT3 in immune suppression and describe current therapeutic strategies that target the JAK/STAT3 signaling axis for the treatment of malignancies.

journal_name

Semin Cancer Biol

authors

Huynh J,Etemadi N,Hollande F,Ernst M,Buchert M

doi

10.1016/j.semcancer.2017.06.001

subject

Has Abstract

pub_date

2017-08-01 00:00:00

pages

13-22

eissn

1044-579X

issn

1096-3650

pii

S1044-579X(17)30150-5

journal_volume

45

pub_type

杂志文章,评审
  • Immunotherapy of cancer using cytokine gene-modified tumor vaccines.

    abstract::Distant metastasis is the major cause for therapeutic failures in clinical oncology. Active immunotherapy of patients with low tumor burden would not only contribute to further reduction of the remaining tumor burden to subclinical levels, but it would also establish a constant state of immunity, i.e. immunological me...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:

    authors: Gilboa E,Lyerly HK,Vieweg J,Saito S

    更新日期:1994-12-01 00:00:00

  • Uveal melanoma pathobiology: Metastasis to the liver.

    abstract::Uveal melanoma (UM) is a type of intraocular tumor with a propensity to disseminate to the liver. Despite the identification of the early driver mutations during the development of the pathology, the process of UM metastasis is still not fully comprehended. A better understanding of the genetic, molecular, and environ...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章

    doi:10.1016/j.semcancer.2020.05.003

    authors: Bustamante P,Piquet L,Landreville S,Burnier JV

    更新日期:2020-05-22 00:00:00

  • Cellular and viral ligands that interact with the EGF receptor.

    abstract::The growth regulatory functions of a family of structurally related polypeptides are mediated through the membrane-bound epidermal growth factor receptor molecule. This ligand family includes epidermal growth factor, transforming growth factor-alpha, amphiregulin, and polypeptides encoded by several poxviruses. The st...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:

    authors: Todaro GJ,Rose TM,Spooner CE,Shoyab M,Plowman GD

    更新日期:1990-08-01 00:00:00

  • Metabolic reprogramming in cancer cells, consequences on pH and tumour progression: Integrated therapeutic perspectives with dietary lipids as adjuvant to anticancer treatment.

    abstract::While tumours arise from acquired mutations in oncogenes or tumour-suppressor genes, it is clearly established that cancers are metabolic diseases characterized by metabolic alterations in tumour cells, and also non-tumour cells of the host organism resulting in tumour cachexia and patient weakness. In this review, we...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2017.03.004

    authors: Dumas JF,Brisson L,Chevalier S,Mahéo K,Fromont G,Moussata D,Besson P,Roger S

    更新日期:2017-04-01 00:00:00

  • The impact of CD4+CD25+ Treg on tumor specific CD8+ T cell cytotoxicity and cancer.

    abstract::There is sufficient evidence to suggest that tumor growth elicits specific immune responses, including CD8(+) and CD4(+) T cell responses that may delay tumor growth and could potentially be harnessed to eradicate cancer. Nevertheless the frequent outcome of cancer is lethality associated with uncontrolled growth and ...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2005.11.006

    authors: Khazaie K,von Boehmer H

    更新日期:2006-04-01 00:00:00

  • Molecular and pathological characterization of inherited breast cancer.

    abstract::The two major breast cancer susceptibility genes, BRCA1 and BRCA2, account for the majority of familial breast-ovarian cancer, but only a modest proportion of breast cancer families without ovarian or male breast cancer. Search for additional breast cancer genes with traditional linkage analysis has so far been unsucc...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1006/scbi.2001.0393

    authors: Borg A

    更新日期:2001-10-01 00:00:00

  • Nanotechnology, in silico and endocrine-based strategy for delivering paclitaxel and miRNA: Prospects for the therapeutic management of breast cancer.

    abstract::Breast cancer is one of the most prevalent and reoccurring cancers and the second most common reason of death in women. Despite advancements in therapeutic strategies for breast cancer, early tumor recurrence and metastasis in patients indicate resistance to chemotherapeutic medicines, such as paclitaxel due to the ab...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2019.12.022

    authors: Ansari MA,Thiruvengadam M,Farooqui Z,Rajakumar G,Sajid Jamal QM,Alzohairy MA,Almatroudi A,Alomary MN,Chung IM,Al-Suhaimi EA

    更新日期:2019-12-28 00:00:00

  • Proteomic research in sarcomas - current status and future opportunities.

    abstract::Sarcomas are a rare group of mesenchymal cancers comprising over 70 different histological subtypes. For the majority of these diseases, the molecular understanding of the basis of their initiation and progression remains unclear. As such, limited clinical progress in prognosis or therapeutic regimens have been made o...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2019.11.003

    authors: Burns J,Wilding CP,L Jones R,H Huang P

    更新日期:2020-04-01 00:00:00

  • Homeostatic interplay between FoxO proteins and ER proteostasis in cancer and other diseases.

    abstract::Cancer cells are exposed to adverse conditions within the tumor microenvironment that challenge cells to adapt and survive. Several of these homeostatic perturbations insults alter the normal function of the endoplasmic reticulum (ER), resulting in the accumulation of misfolded proteins. ER stress triggers a conserved...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2018.01.011

    authors: González-Quiroz M,Urra H,Limia CM,Hetz C

    更新日期:2018-06-01 00:00:00

  • The retinoblastoma protein and its relatives.

    abstract::The retinoblastoma tumor suppressor gene is inactivated in retinoblastomas and a variety of other tumor types. In addition, it is one of several cellular proteins targeted by the transforming proteins of the small DNA tumor viruses. At least two other cellular proteins that are targeted by the viral transforming prote...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1006/scbi.1995.0011

    authors: Whyte P

    更新日期:1995-04-01 00:00:00

  • Evolving paradigms in multifocal breast cancer.

    abstract::The 7th edition of the TNM defines multifocal breast cancer as multiple simultaneous ipsilateral and synchronous breast cancer lesions, provided they are macroscopically distinct and measurable using current traditional pathological and clinical tools. According to the College of American Pathologists (CAP), the chara...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2014.07.002

    authors: Salgado R,Aftimos P,Sotiriou C,Desmedt C

    更新日期:2015-04-01 00:00:00

  • Environmental and chemical carcinogenesis.

    abstract::People are continuously exposed exogenously to varying amounts of chemicals that have been shown to have carcinogenic or mutagenic properties in experimental systems. Exposure can occur exogenously when these agents are present in food, air or water, and also endogenously when they are products of metabolism or pathop...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2004.06.010

    authors: Wogan GN,Hecht SS,Felton JS,Conney AH,Loeb LA

    更新日期:2004-12-01 00:00:00

  • Growing evidence that several human cancers may originate in utero.

    abstract::Hormone-related cancers may originate in utero. Accumulating evidence is given by animal studies, descriptive epidemiologic data and analytic etiologic studies. Indicators of high levels of endogenous pregnancy hormones, like high birth weight and jaundice in the offspring, are associated with increased risk for breas...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1006/scbi.1998.0073

    authors: Ekbom A

    更新日期:1998-08-01 00:00:00

  • Gut microbiome: A possible common therapeutic target for treatment of atherosclerosis and cancer.

    abstract::Human gut microbiota is a dynamic and variable system that can change over time and in response to different diets and treatments. There is currently no doubt that gut microbiota can provide interesting therapeutic opportunities, since it can metabolize biologically active molecules, drugs, and their precursors, and c...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章

    doi:10.1016/j.semcancer.2020.06.017

    authors: Wu WK,Ivanova EA,Orekhov AN

    更新日期:2020-06-28 00:00:00

  • PIWI-interacting RNAs in human cancer.

    abstract::P-element-induced wimpy testis (PIWI) interacting RNAs (piRNAs) are a class of small regulatory RNAs mechanistically similar to but much less studied than microRNAs and small interfering RNAs. Today the best understood function of piRNAs is transposon control in animal germ cells, which has earned them the name 'guard...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章

    doi:10.1016/j.semcancer.2020.08.012

    authors: Lin Y,Zheng J,Lin D

    更新日期:2020-09-01 00:00:00

  • Metallothionein expression and transient resistance to electrophilic antineoplastic drugs.

    abstract::Intrinsic and acquired resistance to antineoplastic agents remains an important impediment to cancer therapy. Intracellular metallothioneins appear to be one factor in determining the responsiveness of malignant and normal cells to electrophilic anticancer agents. Metallothioneins are not only constitutively expressed...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:

    authors: Lazo JS,Basu A

    更新日期:1991-08-01 00:00:00

  • Targeting the ubiquitin-proteasome system to activate wild-type p53 for cancer therapy.

    abstract::Ubiquitination plays a key role in regulating the tumour suppressor p53. It targets p53 for degradation by the 26S proteasome. The ubiquitin pathway also regulates the activity and localisation of p53. Ubiquitination requires ubiquitin-activating and -conjugating enzymes and ubiquitin ligases. In addition, ubiquitinat...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2009.10.004

    authors: Allende-Vega N,Saville MK

    更新日期:2010-02-01 00:00:00

  • What patents tell us about drug repurposing for cancer: A landscape analysis.

    abstract::Intellectual property documents (patents and their published applications) are not only collections of legal exclusivity claims but also repositories of scientific and technical information, even though they are not peer reviewed. We have identified and analyzed international disclosures concerning drug repurposing fo...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2019.09.010

    authors: Mucke HAM

    更新日期:2019-09-20 00:00:00

  • Tumor biology and multidisciplinary strategies of oligometastasis in gastrointestinal cancers.

    abstract::More than 70% of gastrointestinal (GI) cancers are diagnosed with metastases, leading to poor prognosis. For some cancer patients with limited sites of metastatic tumors, the term oligometastatic disease (OMD) has been coined as opposed to systemic polymetastasis (PMD) disease. Stephan Paget first described an organ-s...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2019.08.026

    authors: Zhao Y,Li J,Li D,Wang Z,Zhao J,Wu X,Sun Q,Lin PP,Plum P,Damanakis A,Gebauer F,Zhou M,Zhang Z,Schlösser H,Jauch KW,Nelson PJ,Bruns CJ

    更新日期:2020-02-01 00:00:00

  • Liver cancer epidemic in China: past, present and future.

    abstract::Primary liver cancer is the second most common malignancy, and currently results in 360,000 incident cases, and 350,000 deaths a year in China. For the past four decades, three national surveys on cancer mortality during the periods of 1973-1975, 1990-1992, and 2004-2005 have made it possible to estimate China's past ...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2010.11.002

    authors: Chen JG,Zhang SW

    更新日期:2011-02-01 00:00:00

  • The bcl-2 gene family.

    abstract::Viability is a fundamental determinant of all cellular functions, and regulation of cell viability is important in shaping tissue differentiation and organism development. The genes in the bcl-2 family can profoundly influence cell viability. In addition to bcl-2, cellular genes in this family include bcl-x, bax, mcl-...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1006/scbi.1995.0005

    authors: Craig RW

    更新日期:1995-02-01 00:00:00

  • The microenvironments of multistage carcinogenesis.

    abstract::Overt neoplasia is often the result of a chronic disease process encompassing an extended segment of the lifespan of any species. A common pathway in the natural history of the disease is the appearance of focal proliferative lesions that are known to act as precursors for cancer development. It is becoming increasing...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2008.03.019

    authors: Laconi E,Doratiotto S,Vineis P

    更新日期:2008-10-01 00:00:00

  • Role of AHR in the control of GBM-associated myeloid cells.

    abstract::Glioblastoma (GBM) is an aggressive and incurable brain tumor; its malignancy has been associated with the activity of tumor infiltrating myeloid cells. Myeloid cells play important roles in the tumor control by the immune response, but also in tumor progression. Indeed, GBM exploits multiple mechanisms to recruit and...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2019.05.014

    authors: Gabriely G,Quintana FJ

    更新日期:2020-08-01 00:00:00

  • Cathepsin B and tumor proteolysis: contribution of the tumor microenvironment.

    abstract::Tumor-stromal interactions induce expression of matrix metalloproteinases and serine proteases and, as shown recently, the cysteine protease cathepsin B. We speculate that such interactions upregulate the transcription factor Ets1, resulting in increased cathepsin B expression. This would be consistent with the observ...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2004.08.001

    authors: Sloane BF,Yan S,Podgorski I,Linebaugh BE,Cher ML,Mai J,Cavallo-Medved D,Sameni M,Dosescu J,Moin K

    更新日期:2005-04-01 00:00:00

  • Tumor metabolism as modulator of immune response and tumor progression.

    abstract::About a century ago Otto Warburg observed that tumor cells exhibited increased glycolysis despite the presence of oxygen and stated this metabolic shift to glycolysis as the origin of cancer cell. In the meantime it has become clear, that the altered glucose metabolism is only one piece of the tumor metabolome puzzle....

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2012.02.009

    authors: Gottfried E,Kreutz M,Mackensen A

    更新日期:2012-08-01 00:00:00

  • Bioblockades join the assault on small G protein signalling.

    abstract::Inhibition of Ras signalling has been a goal almost since its central role in cell signalling and its deregulation in disease were discovered. Early attempts at inhibiting its post-translational modification using peptidomimetics were successful in cell culture but failed spectacularly in clinical trials, making indus...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2018.01.001

    authors: Mott HR,Owen D

    更新日期:2019-02-01 00:00:00

  • Intracellular signaling and hepatocellular carcinoma.

    abstract::Liver cancer is the fifth most common cancer and the third most common cause of cancer related death in the world. The recent development of new techniques for the investigations of global change in the gene expression, signaling pathways and wide genome binding has provided novel information for the mechanisms underl...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2010.09.001

    authors: Iakova P,Timchenko L,Timchenko NA

    更新日期:2011-02-01 00:00:00

  • Oncogenes and muscle differentiation: multiple mechanisms of interference.

    abstract::In vitro transformation of replicating myogenic cells by a variety of oncogenes is always accompanied by inhibition of the transition to the terminally differentiated state. Three main levels of interference by oncogenes may ultimately prevent transcription of skeletal muscle-specific genes. First, the transcription o...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章

    doi:

    authors: Alemà S,Tatò F

    更新日期:1994-04-01 00:00:00

  • Mitogen-activated protein kinases in hepatocellular carcinoma development.

    abstract::Hepatocellular carcinoma (HCC) is among the most frequently occurring cancers and the leading causes of cancer mortality worldwide. Identification of the signaling pathways regulating liver carcinogenesis is critical in developing novel chemoprevention and targeted therapies. Mitogen-activated protein kinases (MAPKs),...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2010.10.011

    authors: Min L,He B,Hui L

    更新日期:2011-02-01 00:00:00

  • Cytotoxic T lymphocyte therapy of cancer and tumor escape mechanisms.

    abstract::In animal models complete and permanent eradication of tumors can be achieved by adoptive transfer of tumor specific T cells, combined with interleukin 2. The most active cells are CD8+ cytotoxic T lymphocytes (CTL), which recognize peptides of 8-10 amino acids in length, bound to the antigen presenting groove of MHC ...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:

    authors: Melief CJ,Kast WM

    更新日期:1991-10-01 00:00:00